ETRACS 2xMonthly Leveraged S&P MLP Index ETN Series B
MLPZ
MLPZ was delisted on the 23rd of March, 2020.
0 hedge funds and large institutions have $0 invested in ETRACS 2xMonthly Leveraged S&P MLP Index ETN Series B in 2017 Q3 according to their latest regulatory filings, with funds opening new positions, 0 increasing their positions, reducing their positions, and 1 closing their positions.
100% less funds holding
Funds holding: 1 → 0 (-1)
100% less capital invested
Capital invested by funds: $494K → $0 (-$494K)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCA
Salient Capital Advisors
Houston,
Texas
|
-$494K |
MLPZ Hedge Fund Activity: Q3 2017 in Review
0 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in ETRACS 2xMonthly Leveraged S&P MLP Index ETN Series B (MLPZ) for Q3 2017, worth a combined $0 — down 100% from $494K a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of MLPZ and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 0 added.
The largest seller was Salient Capital Advisors, exiting entirely with an estimated $494K sold.
- 0 institutional investors held ETRACS 2xMonthly Leveraged S&P MLP Index ETN Series B (MLPZ) as of Q3 2017, down from 1 in Q2 2017.
- Funds reported $0 of ETRACS 2xMonthly Leveraged S&P MLP Index ETN Series B stock for Q3 2017, down 100% quarter-over-quarter.
- 0 funds opened new ETRACS 2xMonthly Leveraged S&P MLP Index ETN Series B positions in Q3 2017 and 1 closed out, a net change of -1 holder.
- The largest ETRACS 2xMonthly Leveraged S&P MLP Index ETN Series B seller in Q3 2017 was Salient Capital Advisors, an estimated $494K sold.
Based on aggregated 13F filings for Q3 2017.